Huntington disease (HD) is an autosomal-dominant neurodegenerative disorder that primarily affects medium spiny striatal neurons (MSN). The symptoms are choreiform, involuntary movements, personality changes and dementia. HD is caused by a CAG repeat expansion in the IT15 gene, which results in a long stretch of polyglutamine (polyQ) close to the amino-terminus of the HD protein huntingtin (Htt). Mutant Htt (mHtt) has effects both in the cytoplasm and in the nucleus. Full-length huntingtin is cleaved by proteases in the cytoplasm, leading to the formation of cytoplasmic and neuritic aggregates. mHtt also alters vesicular transport and recycling, causes cytosolic and mitochondrial Ca2+  overload, triggers endoplasmic reticulum stress through proteasomal dysfunction, and impairs autophagy function, increasing neuronal death susceptibility. N-terminal fragments containing the polyQ strech translocate to the nucleus where they impair transcription and induce neuronal death.

Human Diseases; Neurodegenerative disease

Mus musculus (mouse) [GN:mmu]

PMID:15459747

Landles C, Bates GP

Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series.

EMBO Rep 5:958-63 (2004)
DOI:10.1038/sj.embor.7400250

PMID:17041811

Borrell-Pages M, Zala D, Humbert S, Saudou F

Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.

Cell Mol Life Sci 63:2642-60 (2006)
DOI:10.1007/s00018-006-6242-0

PMID:18951640

Bossy-Wetzel E, Petrilli A, Knott AB

Mutant huntingtin and mitochondrial dysfunction.

Trends Neurosci 31:609-16 (2008)
DOI:10.1016/j.tins.2008.09.004

PMID:16288298

Cattaneo E, Zuccato C, Tartari M

Normal huntingtin function: an alternative approach to Huntington's disease.

Nat Rev Neurosci 6:919-30 (2005)
DOI:10.1038/nrn1806

PMID:15336977

Bezprozvanny I, Hayden MR

Deranged neuronal calcium signaling and Huntington disease.

Biochem Biophys Res Commun 322:1310-7 (2004)
DOI:10.1016/j.bbrc.2004.08.035

PMID:14526190

Sawa A, Tomoda T, Bae BI

Mechanisms of neuronal cell death in Huntington's disease.

Cytogenet Genome Res 100:287-95 (2003)
DOI:10.1159/000072864

PMID:12372277

Ross CA.

Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.

Neuron 35:819-22 (2002)
DOI:10.1016/S0896-6273(02)00872-3

PMID:15242639

Ross CA

Huntington's disease: new paths to pathogenesis.

Cell 118:4-7 (2004)
DOI:10.1016/j.cell.2004.06.022

PMID:24739785

Coffey ET

Nuclear and cytosolic JNK signalling in neurons.

Nat Rev Neurosci 15:285-99 (2014)
DOI:10.1038/nrn3729

PMID:19525941

Morfini GA, You YM, Pollema SL, Kaminska A, Liu K, Yoshioka K, Bjorkblom B, Coffey ET, Bagnato C, Han D, Huang CF, Banker G, Pigino G, Brady ST

Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.

Nat Neurosci 12:864-71 (2009)
DOI:10.1038/nn.2346

PMID:26920688

Kumar P, Kumar D, Jha SK, Jha NK, Ambasta RK

Ion Channels in Neurological Disorders.

Adv Protein Chem Struct Biol 103:97-136 (2016)
DOI:10.1016/bs.apcsb.2015.10.006

PMID:25191533

Proft J, Weiss N

Rectifying rectifier channels in Huntington disease.

Commun Integr Biol 7:e29410 (2014)
DOI:10.4161/cib.29410

PMID:15695335

Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, Kristal BS, Hayden MR, Bezprozvanny I

Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.

Proc Natl Acad Sci U S A 102:2602-7 (2005)
DOI:10.1073/pnas.0409402102

PMID:29427371

Mackay JP, Nassrallah WB, Raymond LA

Cause or compensation?-Altered neuronal Ca(2+) handling in Huntington's disease.

CNS Neurosci Ther 24:301-310 (2018)
DOI:10.1111/cns.12817

PMID:11807533

Mattson MP.

Accomplices to neuronal death.

Nature 415:377-9 (2002)
DOI:10.1038/415377a

PMID:17081970

McGill JK, Beal MF

PGC-1alpha, a new therapeutic target in Huntington's disease?

Cell 127:465-8 (2006)
DOI:10.1016/j.cell.2006.10.023

PMID:30941017

Intihar TA, Martinez EA, Gomez-Pastor R

Mitochondrial Dysfunction in Huntington's Disease; Interplay Between HSF1, p53 and PGC-1alpha Transcription Factors.

Front Cell Neurosci 13:103 (2019)
DOI:10.3389/fncel.2019.00103

PMID:15996541

La Spada AR, Morrison RS

The power of the dark side: Huntington's disease protein and p53 form a deadly alliance.

Neuron 47:1-3 (2005)
DOI:10.1016/j.neuron.2005.06.023

PMID:11738471

Lesort M, Chun W, Tucholski J, Johnson GV

Does tissue transglutaminase play a role in Huntington's disease?

Neurochem Int 40:37-52 (2002)
DOI:10.1016/S0197-0186(01)00059-6

PMID:15996546

Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A

p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.

Neuron 47:29-41 (2005)
DOI:10.1016/j.neuron.2005.06.005

PMID:11839795

Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ

Interaction of Huntington disease protein with transcriptional activator Sp1.

Mol Cell Biol 22:1277-87 (2002)
DOI:10.1128/MCB.22.5.1277-1287.2002

PMID:25270767

Vidal RL, Matus S, Bargsted L, Hetz C

Targeting autophagy in neurodegenerative diseases.

Trends Pharmacol Sci 35:583-91 (2014)
DOI:10.1016/j.tips.2014.09.002

PMID:16522639

Shibata M, Lu T, Furuya T, Degterev A, Mizushima N, Yoshimori T, MacDonald M, Yankner B, Yuan J

Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1.

J Biol Chem 281:14474-85 (2006)
DOI:10.1074/jbc.M600364200